|
BRAF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.97309999999873E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.305750E-01 |
| Normal-vs-Stage2 |
1.475990E-01 |
| Normal-vs-Stage3 |
1.19639999995869E-06 |
| Normal-vs-Stage4 |
6.84480000456844E-08 |
| Stage1-vs-Stage2 |
6.657800E-01 |
| Stage1-vs-Stage3 |
9.815600E-04 |
| Stage1-vs-Stage4 |
4.17099999999726E-05 |
| Stage2-vs-Stage3 |
4.432000E-02 |
| Stage2-vs-Stage4 |
7.261300E-03 |
| Stage3-vs-Stage4 |
4.217200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.232800E-04 |
| Normal-vs-AfricanAmerican |
2.26809999999134E-05 |
| Normal-vs-Asian |
6.244000E-01 |
| Caucasian-vs-AfricanAmerican |
3.400400E-02 |
| Caucasian-vs-Asian |
1.752990E-01 |
| AfricanAmerican-vs-Asian |
2.446000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33809999997214E-06 |
| Normal-vs-Female |
3.642200E-02 |
| Male-vs-Female |
1.009160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.200400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.087500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.64480000000022E-05 |
| Normal-vs-Age(81-100Yrs) |
1.742040E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.026800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.262800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.369800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.122300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.223210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.044400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.478000E-01 |
| Normal-vs-Grade 2 |
4.990500E-02 |
| Normal-vs-Grade 3 |
3.360600E-04 |
| Normal-vs-Grade 4 |
1.72559999622734E-09 |
| Grade 1-vs-Grade 2 |
1.393570E-01 |
| Grade 1-vs-Grade 3 |
5.150400E-02 |
| Grade 1-vs-Grade 4 |
3.808300E-04 |
| Grade 2-vs-Grade 3 |
8.745900E-02 |
| Grade 2-vs-Grade 4 |
2.27819999999435E-05 |
| Grade 3-vs-Grade 4 |
2.500100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.944200E-01 |
| Normal-vs-ccB subtype |
1.9727199999986E-05 |
| ccA subtype-vs-ccB subtype |
1.92068000000045E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.575900E-03 |
| Normal-vs-N1 |
2.285600E-02 |
| N0-vs-N1 |
1.241030E-01 |
|
|
